Skip to content

Clinical trials

Phase 1/2 Alzheimer Disease trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Phase: Phase 1/2 Country / region: United States Clear all

67 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20061
20071
20081
20092
20102
20122
20132
20142
20154
20161
20175
20183
20193
20206
20218
20226
20235
20244
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37
Recruiting13
Terminated4
Unknown status4
Not yet recruiting3
Active, not recruiting3
Withdrawn3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Brigham and Women's Hospital3
Massachusetts General Hospital3
Alzamend Neuro, Inc.2
Annovis Bio Inc.2
Jeff Burns, MD2
Oregon Health and Science University2
The University of Texas Health Science Center at San Antonio2
University of California, Los Angeles2
AC Immune SA1
AbbVie1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease67
Dementia17
Cognitive Dysfunction12
Inflammation4
Central Nervous System Diseases3
Parkinson Disease3
Amyotrophic Lateral Sclerosis2
Anxiety Disorders2
Brain Diseases2
Down Syndrome2

Trials

Showing 1 to 25 of 67. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.